Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) shares passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.12 and traded as low as $0.0001. Arch Therapeutics shares last traded at $0.00, with a volume of 0 shares traded.
Arch Therapeutics Stock Down 100.0%
The stock has a fifty day moving average price of $0.12.
About Arch Therapeutics
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Featured Stories
- Five stocks we like better than Arch Therapeutics
- What is a SEC Filing?
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- How to Use Stock Screeners to Find Stocks
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
